Active substance
Dipyridamole
- SFDA 5
- US FDA 26
- Health Canada 2
- US price lines 3
- NHS prices 4
- Safety 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ANTIPLATE 75MG TAB | 75 mg | Film-coated tablet · Oral use | 50 Blister | SAR 20.10 | Generic · Prescription | APM | Valid |
| NOVO-DIPIRADOL 25MG TAB | 25 mg | Tablet · Oral use | 100 Blister | SAR 28.10 | NCE · Prescription | NOVOPHARM | Withdrawn by MAH · Not Marketed |
| NOVO-DIPIRADOL 25MG TAB | 25 mg | Tablet · Oral use | 30 Blister | SAR 11.70 | NCE · Prescription | NOVOPHARM | Withdrawn by MAH · Not Marketed |
| NOVO-DIPIRADOL 75MG TAB | 75 mg | Tablet · Oral use | 30 Blister | SAR 18.80 | NCE · Prescription | NOVOPHARM | Withdrawn by MAH · Not Marketed |
| NOVO-DIPIRADOL 75MG TAB | 75 mg | Tablet · Oral use | 100 Blister | SAR 62.60 | NCE · Prescription | NOVOPHARM | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| DIPYRIDAMOLE | 25MG | tablet · oral | BARR | Prescription | 29 Sep 1980 |
| DIPYRIDAMOLE | 50MG | tablet · oral | BARR | Prescription | 3 Oct 1990 |
| DIPYRIDAMOLE | 75MG | tablet · oral | BARR LABS | Prescription | 3 Oct 1990 |
| DIPYRIDAMOLE | 5MG/ML | injectable · injection | HIKMA PHARMS | Prescription | 18 Oct 1996 |
| DIPYRIDAMOLE | 5MG/ML | injectable · injection | CHARTWELL INJECTABLE | Prescription | 13 Apr 1998 |
| DIPYRIDAMOLE | 25MG; 50MG; 75MG | tablet · oral | OXFORD PHARMS | Prescription | 21 Apr 2006 |
| DIPYRIDAMOLE | 25MG; 50MG; 75MG | tablet · oral | RISING | Prescription | 13 Feb 2007 |
| DIPYRIDAMOLE | 25MG; 50MG; 75MG | tablet · oral | IMPAX LABS | Prescription | 18 Jul 2007 |
| DIPYRIDAMOLE | 25MG; 50MG; 75MG | tablet · oral | ZYDUS PHARMS USA INC | Prescription | 28 Jan 2008 |
| PERSANTINE | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | BOEHRINGER INGELHEIM | Discontinued | 6 Dec 1961 |
| IV PERSANTINE | 5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable · injection | BOEHRINGER INGELHEIM | Discontinued | 13 Dec 1990 |
| DIPYRIDAMOLE | 25MG | tablet · oral | GLENMARK GENERICS | Discontinued | 5 Feb 1991 |
| DIPYRIDAMOLE | 50MG | tablet · oral | GLENMARK GENERICS | Discontinued | 5 Feb 1991 |
| DIPYRIDAMOLE | 75MG | tablet · oral | GLENMARK GENERICS | Discontinued | 5 Feb 1991 |
| DIPYRIDAMOLE | 50MG; 25MG; 75MG | tablet · oral | ANI PHARMS | Discontinued | 16 Apr 1991 |
| DIPYRIDAMOLE | 75MG | tablet · oral | IDT AUSTRALIA LTD | Discontinued | 25 Feb 1992 |
| DIPYRIDAMOLE | 50MG | tablet · oral | IDT AUSTRALIA LTD | Discontinued | 25 Feb 1992 |
| DIPYRIDAMOLE | 50MG | tablet · oral | WATSON LABS | Discontinued | 7 Jun 1996 |
| DIPYRIDAMOLE | 5MG/ML | injectable · injection | DR REDDYS | Discontinued | 26 Nov 1997 |
| DIPYRIDAMOLE | 5MG/ML | injectable · injection | HOSPIRA | Discontinued | 19 Dec 1997 |
| DIPYRIDAMOLE | 5MG/ML | injectable · injection | FRESENIUS KABI USA | Discontinued | 30 Sep 1998 |
| DIPYRIDAMOLE | 75MG | tablet · oral | PUREPAC PHARM | Discontinued | 3 Jan 2000 |
| DIPYRIDAMOLE | 5MG/ML | injectable · injection | EUGIA PHARMA SPECLTS | Discontinued | 27 Nov 2002 |
| DIPYRIDAMOLE | 25MG; 50MG; 75MG | tablet · oral | CHARTWELL RX | Discontinued | 23 Apr 2008 |
| DIPYRIDAMOLE | 25MG | tablet · oral | PUREPAC PHARM | Discontinued |
1 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| DIPYRIDAMOLE INJECTION, USP | 02244475 | 5 MG / ML | LIQUID · INTRAVENOUS | FRESENIUS KABI CANADA LTD |
| PERSANTINE | 00637734 | 5 MG / ML | SOLUTION · INTRAVENOUS | GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | DIPYRIDAMOLE 25 MG TABLET | $0.1359 | per EA | 23 Sep 2026 |
| US NADAC | DIPYRIDAMOLE 50 MG TABLET | $0.35731 | per EA | 23 Sep 2026 |
| US NADAC | DIPYRIDAMOLE 75 MG TABLET | $0.23583 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Dipyridamole 100mg tablets | £43.98 | 84 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Dipyridamole 200mg modified-release capsules | £13.15 | 60 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Dipyridamole 25mg tablets | £8.67 | 84 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Dipyridamole 50mg/5ml oral suspension sugar free | £225.66 | 150 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 13 May 2021 AGGRENOX — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 11 Dec 2019 PERSANTINE — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Drug Interactions
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.